Filing Flows › Comparisons › IDXG vs UTMD
Interpace Biosciences vs Utah Medical Products: IDXG and UTMD compared
Interpace Biosciences is the larger company: $9.1M of revenue in its latest quarter (Q2 2026) against $8.5M for Utah Medical Products (Q2 2026). Interpace Biosciences is growing faster (-1% against -14% a year earlier). Utah Medical Products is more profitable, with an operating margin of 31.1% against 3.5%.
Where the money goes: IDXG and UTMD
Interpace Biosciences (IDXG) · Q2 2026
Interpace Biosciences, Q2 2026: revenue $9.1M (-1% year over year), operating margin 3.5%, net earnings $158K, operating cash flow $98K. The chart follows the revenue to costs, profit and cash.
Utah Medical Products (UTMD) · Q2 2026
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
| Interpace Biosciences (IDXG) | Utah Medical Products (UTMD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $9.1M | $8.5M |
| Revenue growth, Y/Y | -1% | -14% |
| Gross margin | 61.9% | 55.8% |
| Operating margin | 3.5% | 31.1% |
| Net earnings | $158K | $2.7M |
| Net margin | 1.7% | 31.5% |
| Operating cash flow | $98K | $1.4M |
| Free cash flow | $41K | $1.2M |
Where the revenue comes from
Utah Medical Products
- Gynecology/Electrosurgery/Urology: $4.3M (50%)
- Neonatal: $1.9M (22%)
- Blood Pressure Monitoring and Accessories: $1.3M (15%)
- Obstetrics: $1.1M (12%)
Questions
Which is bigger, Interpace Biosciences or Utah Medical Products?
Interpace Biosciences is the larger company: $9.1M of revenue in its latest quarter (Q2 2026) against $8.5M for Utah Medical Products (Q2 2026).
Is Interpace Biosciences or Utah Medical Products growing faster?
Interpace Biosciences is growing faster (-1% against -14% a year earlier).
Which is more profitable, Interpace Biosciences or Utah Medical Products?
Utah Medical Products is more profitable, with an operating margin of 31.1% against 3.5%.
More: Interpace Biosciences earnings · how Interpace Biosciences makes money · Utah Medical Products earnings · how Utah Medical Products makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.